Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Amgen
(NQ:
AMGN
)
334.31
+4.16 (+1.26%)
Streaming Delayed Price
Updated: 10:35 AM EDT, Jul 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Amgen
< Previous
1
2
...
21
22
23
24
25
26
27
28
29
...
43
44
Next >
Horizon Therapeutics (HZNP) Stock Pops on HUGE Amgen Deal
December 12, 2022
HZNP stock is up on news that Horizon Therapeutics is being bought by Amgen in a friendly deal that's positive for both companies.
Via
InvestorPlace
Amgen To Buy Rare Diseases Drugmaker Horizon Therapeutics In $28.3 Billion Deal
December 12, 2022
The deal comes a day after Sanofi dropped out of the bidding process.
Via
Investor's Business Daily
These 2 Nasdaq Stocks Are Soaring on Merger News
December 12, 2022
Find out which companies are attracting interest from prospective buyers.
Via
The Motley Fool
Broadcom-Vmware Deal Draws European Regulatory Attention, Rivian Pauses Mercedes-Partnered EV Van Plans For Europe, Credit Suisse Issued Loan On Suspicious Bills: Top Stories Monday, Dec. 12
December 12, 2022
Reuters Broadcom's Vmware Draws More Regulatory Attention, This Time From EU
Via
Benzinga
Two Down With Sanofi Bowing Out From Horizon Buyout Talks, Amgen Agrees To Buy For $116.5/Share
December 12, 2022
Via
Benzinga
Could Amgen's Heart Disease Candidate Generate Billions in Sales?
December 11, 2022
Amgen recently shared positive clinical trial results for a heart disease drug candidate.
Via
The Motley Fool
How An Eli Lilly Decision Could Light Up The Red-Hot Obesity Landscape — Again
December 09, 2022
Eli Lilly is expected to make a key decision for a next-generation obesity drug.
Via
Investor's Business Daily
Why Mirati Therapeutics Stock Lost Half Its Value In Just Three Days
December 08, 2022
The company is still planning a Phase 3 study in non-small cell lung cancer.
Via
Investor's Business Daily
Here's What We Know So Far About Amgen's Obesity Drug As It Trails Novo Nordisk, Eli Lilly
December 08, 2022
Amgen is trying to play catch-up with Novo Nordisk and Eli Lilly.
Via
Investor's Business Daily
This Monster Dividend Stock Isn't Done Growing
December 08, 2022
Is another deal on the way for Johnson & Johnson?
Via
The Motley Fool
Revolution Medicines Regains Global Rights To Mid-Stage Cancer Program As Sanofi Terminates Collaboration
December 08, 2022
Via
Benzinga
Mirati Therapeutics Crashes As The Cancer Rivalry With Amgen Heats Up
December 06, 2022
The combination with Keytruda appears safe, but effectiveness questions persist.
Via
Investor's Business Daily
Mirati Experimental Lung Cancer Drug Shows Favorable Tolerability, Promising Efficacy
December 06, 2022
Via
Benzinga
Is AbbVie Stock a Buy Now?
December 06, 2022
The pharmaceutical company prepared well as Humira approaches its patent cliff next year.
Via
The Motley Fool
Amgen Unusual Options Activity For December 05
December 05, 2022
A whale with a lot of money to spend has taken a noticeably bearish stance on Amgen. Looking at options history for Amgen (NASDAQ:AMGN) we detected 13 strange trades.
Via
Benzinga
Horizon Topples After J&J Pulls Out Of Bidding War, Leaving Amgen, Sanofi
December 05, 2022
There are now two companies in the ring for a Horizon takeover.
Via
Investor's Business Daily
7 Christmas Stocks to Buy for Happy Holidays
December 05, 2022
This year took a toll on a lot of portfolios, leaving many investors feeling more like a Grinch than looking for Christmas stocks to buy.
Via
InvestorPlace
FTX Collapse: Lessons for Investors
December 03, 2022
Plus a look at "the dumbest index."
Via
The Motley Fool
Stock Market Rally Fights At Key Level On Powell, Inflation Data, Jobs Report: Weekly Review
December 02, 2022
The S&P 500 is fighting for its 200-day, a critical level for the uptrend.
Via
Investor's Business Daily
If Sanofi Opted For Takeover Of Horizon Therapeutics, It Would Be In Cash
December 02, 2022
Via
Benzinga
Is Amgen Stock a Buy for Income Investors?
December 02, 2022
Amgen's dividend yield is materially higher than the S&P 500 index's yield.
Via
The Motley Fool
Mirati Plays Catch-Up With Amgen, Gilead's 2nd Try With AIDS Drug, Cytokinetics' Adcom Test And More: Key Nov FDA Decisions For Biotech Investors
December 02, 2022
Food and Drug Administration decisions and advisory committee verdicts slated for November were mostly positive. New molecular entity approvals so far this year trail 2021’s tally by about 35%.
Via
Benzinga
Amgen Is The Underdog In Obesity Treatment — But It's Creeping Up On Novo Nordisk, Eli Lilly
December 01, 2022
The battle for the best weight-loss shot is on with Amgen making a push.
Via
Investor's Business Daily
Analyst Forecasts $101-117/Share Offer Price For Horizon Therapeutics' Buyout
November 30, 2022
Via
Benzinga
Why Horizon Therapeutics Stock Is Skyrocketing Today
November 30, 2022
Three big drugmakers could be interested in acquiring Horizon.
Via
The Motley Fool
Why Is Horizon Therapeutics (HZNP) Stock Up 30% Today?
November 30, 2022
Horizon Therapeutics (HZNP) stock is rising higher on Wednesday following reports that the company is considering a buyout.
Via
InvestorPlace
iPhone Pro Shipments May Miss Consensus, Tesla Rival Charts Ambitious Expansion Plan In Mexico, Amazon Cloud Unit To Add More Employees: Top Stories Wednesday, Nov. 30
November 30, 2022
Reuters
Via
Benzinga
Horizon Therapeutics Shares Jump On Confirmation Of Takeover Talks With Several Large Companies
November 30, 2022
Via
Benzinga
Horizon Therapeutics Rockets As It Considers Potential Bids From Amgen, J&J, Sanofi
November 29, 2022
The three companies have until Jan. 10 to decide whether they want to buy Horizon.
Via
Investor's Business Daily
Mild Fed Meeting Minutes Boost Stocks Ahead of Holiday
November 23, 2022
Stocks took home another win on Wednesday, as investors gear up for tomorrow's market closure due to the Thanksgiving holiday.
Via
Talk Markets
< Previous
1
2
...
21
22
23
24
25
26
27
28
29
...
43
44
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.